Updates from clinical trials of Keytruda (pembrolizumab) for melanoma show that besides its known benefits for people with typical melanoma, the treatment is also effective against mucosal melanoma — a rare version of the cancer, growing in mucosal surfaces of the body. Researchers shared their updates at the European Cancer Congress 2017 (ECCO), held recently in … Continue reading Keytruda Benefits Patients with Rare Mucosal Melanoma, Trials Show